May 21, 1996, Ottawa, Ontario - CMG Canadian Marketing
Group, an Ottawa-based technology, marketing and management
consulting firm, has released three exciting Canadian Technology
Reports ª in the life sciences area. All three reports are unique in
that this is the first time information has been collected in these
areas and analyzed in Canada.
These first three reports in the Canadian Technology Report series are:
Cancer R&D in Canada '96
Gene Therapy R&D in Canada '96
Monoclonal Antibody R&D in Canada '96
Each report provides an in-depth review of the Canadian research
and development pipeline, including activities carried out at the
universities, government research laboratories, hospital research
institutes and companies.
These reports were designed for decision-makers involved in
research and development; senior executives of research
organizations, biotechnology and pharmaceutical companies,
venture capital firms, funding agencies and government agencies.
The above reports are available for purchase from CMG. For
further information on these reports, or CMG's consulting services,
please call Peter Kallai at (613) 567-9406.
CMG is an Ottawa based technology, marketing and management
consulting company with both Canadian and international
experience in the life sciences and the biotechnology sectors.
Since its inception in 1990, CMG has delivered over 50 major
consulting projects. With its business and Ph.D. technology
consultants, CMG is uniquely positioned to serve a wide variety
organizations and needs.
CMG Canadian Marketing Group
463 Cambridge Street South, Suite B03
Ottawa, Canada, K1S 5G3
Tel: (613) 567-9406
Fax: (613) 567-9170
Please forward this press release to your colleagues within and
external to your organization who might be interested in these
reports. Thank you.
